PEG化タンパク質市場

Report Highlights

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

PEG化タンパク質の世界市場は、2023年に102億ドルから成長し、2023年から2028年の予測期間中に9.4%の年間平均成長率(CAGR)で、2028年末までに159億ドルに達すると予測されています。

Report Scope
This report highlights the current and future market potential of PEGylated proteins and provides a detailed analysis of the drivers, restraints, and opportunities in this market. The report also surveys the competitive environment for PEGylated proteins, including coverage of the pipeline activities adopted by players in this market, and it includes market projections for 2028. Also included are company profiles of key players featuring detailed information about each company’s business segments, financials, product portfolios and recent developments. The report does not cover PEGylated vaccines.
In this report, the global market for PEGylated proteins market is segmented into four regions: North America, Europe, Asia-Pacific and Rest of the World. For market estimates, data is provided for 2020 and 2021 (which serve as the historic years), for 2022 (the base year), and forecast for 2028.

Report Synopsis

Report Includes
– 41 data tables and 22 additional tables
– Analysis of the PEGylated proteins market
– Analyses of global market trends, with revenue data for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
– Estimates of the current market size and revenue growth prospects, along with a market share analysis by product and services, protein type, application, and region
– Facts and figures pertaining to the market drivers, opportunities and restraints, and the impact of macroeconomic variables
– An analysis of recent patent grants and published patents
– A look at emerging technologies and regulatory issues
– Overview of sustainability trends and ESG developments, including consumer attitudes, companies’ ESG score rankings and their ESG practices
– Insight into the competitive landscape, including companies’ market shares, business segments, financials and product portfolios, as well as recent M&A activity and venture funding outlook
– Profiles of the major market players

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Introduction
Advantages of Protein PEGylation
Limitations of PEGylated Therapeutics
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Protein Drugs in Hematology and Oncology
Design of Biobetters
Market Restraints
Immunogenicity and Side Effects
Formulation Challenges
Market Opportunities
Site-Specific PEGylation
New Indications and Formulation Techniques
Chapter 4 Emerging Technologies and Developments
Introduction
Non-Covalent PEGylation
PEGylation of Nanoparticles
Antibody-Drug Conjugates (ADCs)
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Global PEGylated Proteins Market, by Protein Type
Granulocyte-Colony Stimulating Factors (G-CSF)
PEGylated Monoclonal Antibodies
PEGylated Interferons
PEGylated Recombinant Factors
Other Protein Types
Global PEGylated Proteins Market, by PEGylation Type
Linear PEGylated Proteins
Branched PEGylated Proteins
Global PEGylated Proteins Market, by PEGylation Application
Autoimmune Diseases
Hematology
Cancer
Other Applications
Geographic Breakdown
Global Market for PEGylated Proteins, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Recent Developments in the PEGylated Proteins Market
Clinical Trial Activities
Chapter 7 Sustainability in the PEGylated Proteins Market: ESG Perspective
Introduction
Sustainability in the PEGylated Proteins Industry
Understanding the ESG Data
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AMGEN INC.
F. HOFFMANN-LA ROCHE LTD.
MERCK KGAA
PFIZER INC.
SANDOZ GROUP AG

List Of Tables

List of Tables
Summary Table : Global Market for PEGylated Proteins, by Region, Through 2028
Table 1 : PEGylated Drugs in Clinical Trials for Cancer
Table 2 : Discontinued PEGylated Drugs in Clinical Trials
Table 3 : Side Effects Observed with Approved Products
Table 4 : Global Market for PEGylated Proteins, by Protein Type, Through 2028
Table 5 : Marketed PEGylated G-CSF Drugs
Table 6 : Global Market for G-CSF, by Region, Through 2028
Table 7 : Global Market for PEGylated mAbs, by Region, Through 2028
Table 8 : Global Market for PEGylated Interferons, by Region, Through 2028
Table 9 : Global Market for PEGylated Recombinant Factors, by Region, Through 2028
Table 10 : Global Market for Other Protein Types, by Region, Through 2028
Table 11 : Global Market for PEGylated Proteins, by PEGylation Type, Through 2028
Table 12 : Global Market for Linear PEGylated Proteins, by Region, Through 2028
Table 13 : Global Market for Branched PEGylated Proteins, by Region, Through 2028
Table 14 : Global Market for PEGylated Proteins, by Application, Through 2028
Table 15 : Global Market for PEGylated Proteins for Autoimmune Diseases, by Region, Through 2028
Table 16 : Global Market for PEGylated Proteins for Hematology, by Region, Through 2028
Table 17 : Global Market for PEGylated Proteins for Cancer, by Region, Through 2028
Table 18 : Global Market for PEGylated Proteins for Other Applications, by Region, Through 2028
Table 19 : Global Market for PEGylated Proteins, by Region, Through 2028
Table 20 : North American Market for PEGylated Proteins, by Country, Through 2028
Table 21 : North American Market for PEGylated Proteins, by Protein Type, Through 2028
Table 22 : North American Market for PEGylated Proteins, by PEGylation Type, Through 2028
Table 23 : North American Market for PEGylated Proteins, by Application, Through 2028
Table 24 : European Market for PEGylated Proteins, by Country, Through 2028
Table 25 : European Market for PEGylated Proteins, by Protein Type, Through 2028
Table 26 : European Market for PEGylated Proteins, by PEGylation Type, Through 2028
Table 27 : European Market for PEGylated Proteins, by Application, Through 2028
Table 28 : Asia-Pacific Market for PEGylated Proteins, by Country, Through 2028
Table 29 : Asia-Pacific Market for PEGylated Proteins, by Protein Type, Through 2028
Table 30 : Asia-Pacific Market for PEGylated Proteins, by PEGylation Type, Through 2028
Table 31 : Asia-Pacific Market for PEGylated Proteins, by Application, Through 2028
Table 32 : RoW Market for PEGylated Proteins, by Protein Type, Through 2028
Table 33 : RoW Market for PEGylated Proteins, by PEGylation Type, Through 2028
Table 34 : RoW Market for PEGylated Proteins, by Application, Through 2028
Table 35 : Recent Developments in PEGylated Proteins Market, 2022 and 2023
Table 36 : Competitor Clinical Trial Activities in PEGylated Protein Therapeutics, by Phase, 2023
Table 37 : ESG Risk Rankings for Major PEGylated Protein Drug Companies*
Table 38 : ESG: Environmental Overview
Table 39 : ESG: Social Overview
Table 40 : ESG: Governance Overview
Table 41 : Report Sources
Table 42 : Abbreviations Used in this Report
Table 43 : Amgen Inc.: Company Snapshot
Table 44 : Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 45 : Amgen Inc.: Product Portfolio
Table 46 : Amgen Inc.: News/Key Developments, 2023
Table 47 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 48 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 49 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 50 : Merck KGaA: Company Snapshot
Table 51 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 52 : Merck KGaA: Product Portfolio
Table 53 : Merck KGaA: News/Key Developments, 2022 and 2023
Table 54 : Pfizer Inc.: Company Snapshot
Table 55 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 56 : Pfizer Inc.: Product Portfolio
Table 57 : Pfizer Inc.: News/Key Developments, 2023
Table 58 : Sandoz Group AG: Company Snapshot
Table 59 : Sandoz Group AG: Financial Performance, FY 2022 and 2023
Table 60 : Sandoz Group AG: Product Portfolio
Table 61 : Sandoz Group AG: News/Key Developments, 2023

List Of Figures

List of Figures
Summary Figure : Global Market for PEGylated Proteins, by Region, 2020-2028
Figure 1 : Advantages of Protein PEGylation
Figure 2 : Timeline of PEGylated Protein Therapeutics
Figure 3 : Disadvantages of PEGylated Protein Therapeutics
Figure 4 : Market Dynamics of Global PEGylated Proteins
Figure 5 : Emerging Technologies in the PEGylated Proteins Market
Figure 6 : Global Market Shares of PEGylated Proteins, by Protein Type, 2022
Figure 7 : Global Market for G-CSF, by Region, 2020–2028
Figure 8 : Global Market for PEGylated mAbs, by Region, 2020-2028
Figure 9 : Global Market for PEGylated Interferons, by Region, 2020-2028
Figure 10 : Global Market for PEGylated Recombinant Factors, by Region, 2020-2028
Figure 11 : Global Market for Other Protein Types, by Region, 2020-2028
Figure 12 : Global Market Shares of PEGylated Proteins, by PEGylation Type, 2022
Figure 13 : Global Market for Linear PEGylated Proteins, 2020-2028
Figure 14 : Global Market for Linear PEGylated Proteins, by Region, 2020–2028
Figure 15 : Global Market for Branched PEGylated Proteins, 2020-2028
Figure 16 : Global Market for Branched PEGylated Proteins, by Region, 2020-2028
Figure 17 : Global Market Shares of PEGylated Proteins, by Application, 2022
Figure 18 : Global Market for PEGylated Proteins for Autoimmune Diseases, 2020-2028
Figure 19 : Global Market for PEGylated Proteins for Autoimmune Diseases, by Region, 2020–2028
Figure 20 : Global Market for PEGylated Proteins for Hematology, 2020-2028
Figure 21 : Global Market for PEGylated Proteins for Hematology, by Region, 2020–2028
Figure 22 : Global Market for PEGylated Proteins for Cancer, 2020-2028
Figure 23 : Global Market for PEGylated Proteins for Cancer, by Region, 2020-2028
Figure 24 : Global Market for PEGylated Proteins for Other Applications, 2020-2028
Figure 25 : Global Market for PEGylated Proteins for Other Applications, by Region, 2020–2028
Figure 26 : Global Market Shares of PEGylated Proteins, by Region, 2022
Figure 27 : Global Market for PEGylated Proteins, by Region, 2020-2028
Figure 28 : North American Market Shares of PEGylated Proteins, by Country, 2022
Figure 29 : European Market Shares of PEGylated Proteins, by Country, 2022
Figure 30 : Asia-Pacific Market Shares of PEGylated Proteins, by Country, 2022
Figure 31 : Snapshot of ESG Pillars
Figure 32 : Advantages of ESG for Companies
Figure 33 : Amgen Inc.: Revenue Share, by Country/Region, FY 2023
Figure 34 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 35 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 36 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 37 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 38 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2023
Figure 39 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
Figure 40 : Sandoz Group AG: Revenue Share, by Business Unit, FY 2023
Figure 41 : Sandoz Group AG: Revenue Share, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 不織布ろ材の世界市場 2025-05-07
• 世界のグリーンスチール市場 2025-05-05
• デジタルパソロジーの技術と世界市場 2025-04-29
• 持続可能エネルギーの調査レビュー　2024年 2025-04-22
• 世界の燃料電池スタック市場 2025-04-22

BCC Research  出版レポート一覧